Astragaloside IV Reprograms Spatial Glycolytic Metabolism in Diabetic Kidney: A Microenvironment‐Targeted Immunometabolic Therapeutic Strategy

ABSTRACT Diabetic nephropathy (DN) remains a major cause of kidney failure, yet current therapies do not adequately target the spatially organized immunometabolic dysfunction that drives disease progression. Astragaloside IV (ASIV), a bioactive saponin derived from Astragalus membranaceus, exhibits...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shi Qiu, Zhibo Wang, Sifan Guo, Dandan Xie, Ying Cai, Xian Wang, Yan Wang, Xiaodan Yu, Jinxuan Chai, Hong Yao, Chunsheng Lin, Qiang Yang, Yu Guan, Qiqi Zhao, Songqi Tang, Wenjie Sun, Yiqiang Xie, Aihua Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-05-01
coleção:	Food Frontiers
Assuntos:	diabetic human kidney glycolytic reprogramming macrophages microregion podocytes spatial transcriptomics
Acesso em linha:	https://doi.org/10.1002/fft2.70295
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!